Viewing Study NCT04596293


Ignite Creation Date: 2025-12-25 @ 1:00 AM
Ignite Modification Date: 2025-12-26 @ 1:33 PM
Study NCT ID: NCT04596293
Status: COMPLETED
Last Update Posted: 2023-09-07
First Post: 2020-10-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Sponsor: Bridge Biotherapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BBT401-UC-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View